dopamine quinone has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranyi, M; Milusheva, E; Sperlágh, B; Vizi, ES | 1 |
| Asanuma, M; Hozumi, H; Miyazaki, I; Miyoshi, K; Sogawa, N | 1 |
2 other study(ies) available for dopamine quinone and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Chromatographic analysis of dopamine metabolism in a Parkinsonian model.
Topics: Adenine Nucleotides; Animals; Catecholamines; Chromatography, Liquid; Corpus Striatum; Dopamine; Insecticides; Male; Models, Chemical; Molecular Structure; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotenone | 2006 |
Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity.
Topics: Animals; Cell Line; Cytoprotection; Dopamine; Dopamine Agents; Levodopa; Metallothionein; Mice; Mice, Knockout; Oxidopamine; Parkinson Disease, Secondary; RNA, Messenger; Zinc | 2007 |